http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 27 May 2026 06:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Press+Releases/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced that it registered certain state-licensed medical cannabis facilities with the U.S. Drug Enforcement Administration (“DEA”) following the federal rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. The registrations are related to dispensary, cultivation and processing operations serving medical cannabis patients in the Company’s footprint. </p><p> “Registering our medical cannabis operations with the DEA marks a significant http://www.streetinsider.com/Business+Wire/Cresco+Labs+Marks+Historic+Step+Forward+with+Medical+Cannabis+Facility+DEA+Registration/26553076.html Wed, 27 May 2026 06:30:00 -0400 6CQ 6CQ A.37042239 CL CRLBF O.02619105 O.21062042 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Press+Releases/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today provided an update on its application under the Texas Compassionate Use Program (TCUP). The Texas Department of Public Safety (DPS) <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dps.texas.gov%2Fnews%2Fdps-releases-corrected-tabulation-texas-compassionate-use-program-expansion&amp;esheet=54533181&amp;newsitemid=20260511242350&amp;lan=en-US&amp;anchor=has+announced&amp;index=1&amp;md5=bbc391008eb8494b938404eaf565c085" shape="rect">has announced</a> a retroactive correction to the tabulation methodology used in its conditional license selection process, impacting multiple applicants. Under the corrected tabulation, the conditional license previously awarded and publicly announced by DPS for Cresco Labs Texas, LLC has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs http://www.streetinsider.com/Business+Wire/Cresco+Labs+Provides+Update+on+Texas+License+Previously+Awarded+by+Texas+Department+of+Public+Safety/26464506.html Mon, 11 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105 http://www.streetinsider.com/Press+Releases/Cresco+Labs+Reports+First+Quarter+2026+Financial+Results%2C+Advances+Multiple+Growth+Initiatives/26457143.html <p> CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“<b>Cresco Labs</b>” or the “<b>Company</b>”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the first quarter ended March 31, 2026. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company’s investor website, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.crescolabs.com%2Foverview%2Fdefault.aspx&amp;esheet=54531786&amp;newsitemid=20260507583575&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=00e2a7e020e601a0fd2bf628652d2fa5" shape="rect">here</a>. </p><p> <b>First Quarter 2026 Highlights</b> </p><ul class="bwlistdisc"> <li> First quarter revenue of $151 million. </li> <li> Gross profit of http://www.streetinsider.com/Press+Releases/Cresco+Labs+Reports+First+Quarter+2026+Financial+Results%2C+Advances+Multiple+Growth+Initiatives/26457143.html Fri, 08 May 2026 06:30:00 -0400 6CQ 6CQ CL CRLBF O.02619105